Coronavirus Disease 2019-Associated Mucormycosis in France: A Rare but Deadly Complication
François Danion, Valérie Letscher‐Bru, J. Guitard, Karine Sitbon, Sarah Dellière, A. Angoulvant, Guillaume Désoubeaux, Françoise Botterel, Anne‐Pauline Bellanger, Gilles Gargala, Fabrice Uhel, Marie‐Elisabeth Bougnoux, Victor Gerber, Justin Michel, Marjorie Cornu, Stéphane Bretagne, Fanny Lanternier, COVID-Mucor study group, Hamid Merdji, Xavier Delabranche, Antoine Parrot, Guillaume Voiriot, Tomas Urbina, Alexandre Mebazaa, Benjamin G. Chousterman, Ahmed El Kalioubie, Sophie Six, Pauline Coulon, Boualem Sendid, Nadia Anguel, Charles Damoisel, Charlotte Mussini, Alban Villate, Jean-Christophe Navellou, Christophe Girault, Carole Cassagne, Olivier Augereau, Françoise Dromer, Dea Garcia‐Hermoso, Olivier Lortholary, Alexandre Alanio
Abstract
We studied COVID-19 associated mucormycosis based on 17 cases reported nationwide and assessed the differences with India. They differed by frequencies of diabetes mellitus (47% in France versus up to 95% in India), hematological malignancies (35% versus 1%), anatomical sites (12% versus >80% rhino-orbito-cerebral) and prognosis (88% mortality versus <50%).